Research ArticleOther Arthritides
Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study
Charlotte L. Bekker, Sacha Bossina, Mary A. de Vera, Susan J. Bartlett, Maarten de Wit, Lyn March, Beverley Shea, Vicki Evans, Dawn Richards, Allison Tong, Peter Tugwell, Kathleen Tymms, Marieke Scholte-Voshaar, Ayano Kelly and Bart J.F. van den Bemt
The Journal of Rheumatology September 2021, 48 (9) 1480-1487; DOI: https://doi.org/10.3899/jrheum.201568
Charlotte L. Bekker
1C.L. Bekker, PhD, Radboud University Medical Centre, Research Institute for Health Sciences, Nijmegen, the Netherlands;
Sacha Bossina
2S. Bossina, MSc, Department of Rheumatology, Liverpool Hospital, Sydney, Australia;
Mary A. de Vera
3M.A. de Vera, Assistant Professor, PhD, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, and Arthritis Research Canada, Richmond, British Columbia, Canada;
Susan J. Bartlett
4S.J. Bartlett, Professor, PhD, Department of Medicine, McGill University and Research Institute, McGill University Health Centres, Montreal, Québec, Canada, and Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA;
Maarten de Wit
5M. de Wit, PhD, OMERACT Patient Research Partner, the Netherlands;
Lyn March
6L. March, Professor, PhD, Institute of Bone and Joint Research, Kolling Institute of Medical Research, and Department of Rheumatology, Royal North Shore Hospital, and Northern Clinical School, The University of Sydney, Sydney, Australia;
Beverley Shea
7B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada;
Vicki Evans
8V. Evans, Adjunct Assistant Professor, PhD, BOptom, Faculty of Health, University of Canberra, Canberra, Australia;
Dawn Richards
9D. Richards, PhD, Five02 Labs Inc., and Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada;
Allison Tong
10A. Tong, Professor, PhD, Centre for Kidney Research, The Children’s Hospital at Westmead, and Sydney School of Public Health, The University of Sydney, Sydney, Australia;
Peter Tugwell
11P. Tugwell, Professor, MD, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada;
Kathleen Tymms
12K. Tymms, Associate Professor, MBBS, FRACP, College of Health and Medicine, Australian National University, and Department of Rheumatology, Canberra Hospital, Canberra, Australia;
Marieke Scholte-Voshaar
13M. Scholte-Voshaar, MSc, OMERACT Patient Research Partner, and University of Twente, Enschede, the Netherlands;
Ayano Kelly
14A. Kelly, Clinical Associate Lecturer, MBBS, FRACP, Department of Rheumatology, Liverpool Hospital, Sydney, Centre for Kidney Research, The Children’s Hospital at Westmead, Sydney, College of Health and Medicine, Australian National University, Canberra, and South Western Clinical School, UNSW Medicine, University of New South Wales, Sydney, Australia;
Bart J.F. van den Bemt
15B.J. van den Bemt, Professor, PharmD, Radboud University Medical Centre, Research Institute for Health Sciences, and Sint Maartenskliniek, Nijmegen, the Netherlands. The authors declare no conflicts of interest relevant to this article.
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- Galo JS,
- Mehat P,
- Rai SK,
- Avina-Zubieta A,
- De Vera MA
- 8.↵
- Kelly A,
- Crimston-Smith L,
- Tong A,
- Bartlett SJ,
- Bekker CL,
- Christensen R, et al.
- 9.↵
- Khan MU,
- Aslani P
- 10.↵
- Srimongkon P,
- Aslani P,
- Chen TF
- 11.↵
- Pednekar PP,
- Agh T,
- Malmenas M,
- Raval AD,
- Bennett BM,
- Borah BJ, et al.
- 12.↵
- Kelly A,
- Bartlett SJ,
- de Wit MP,
- Beaton DE,
- Dawson T,
- Evans V, et al.
- 13.↵
- OMERACT
- 14.↵
- Kelly A,
- Tong A,
- Tymms K,
- March L,
- Craig JC,
- De Vera M, et al; OMERACT-Adherence Group
- 15.↵
- Maxwell LJ,
- Beaton DE,
- Shea BJ,
- Wells GA,
- Boers M,
- Grosskleg S, et al.
- 16.↵
- Boers M,
- Kirwan JR,
- Tugwell P
- 17.↵
- Kelly A,
- Tymms K,
- de Wit M,
- Bartlett SJ,
- Cross M,
- Dawson T, et al.
- 18.↵
- Cheung PP,
- de Wit M,
- Bingham CO , 3rd,
- Kirwan JR,
- Leong A,
- March LM, et al.
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- Owensby JK,
- Chen L,
- O’Beirne R,
- Ruderman EM,
- Harrold LR,
- Melnick JA, et al.
- 30.↵
- 31.↵
In this issue
The Journal of Rheumatology
Vol. 48, Issue 9
1 Sep 2021
Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study
Charlotte L. Bekker, Sacha Bossina, Mary A. de Vera, Susan J. Bartlett, Maarten de Wit, Lyn March, Beverley Shea, Vicki Evans, Dawn Richards, Allison Tong, Peter Tugwell, Kathleen Tymms, Marieke Scholte-Voshaar, Ayano Kelly, Bart J.F. van den Bemt
The Journal of Rheumatology Sep 2021, 48 (9) 1480-1487; DOI: 10.3899/jrheum.201568
Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study
Charlotte L. Bekker, Sacha Bossina, Mary A. de Vera, Susan J. Bartlett, Maarten de Wit, Lyn March, Beverley Shea, Vicki Evans, Dawn Richards, Allison Tong, Peter Tugwell, Kathleen Tymms, Marieke Scholte-Voshaar, Ayano Kelly, Bart J.F. van den Bemt
The Journal of Rheumatology Sep 2021, 48 (9) 1480-1487; DOI: 10.3899/jrheum.201568